Personalized support to help you achieve your health goals
Related Read: 14 Peptides Are About to Become Legal Again What This Means for Your Health What the science says about peptide stacking as a category 1) Combination trials are the exception, not the rule For many popular peptides, we have: mechanistic arguments small studies (sometimes in narrow contexts) preclinical work We rarely have: well-powered, long-term human trials on the combination hard outcomes (function, cardiometabolic endpoints, durability, safety) 2) Stacking amplifies the two biggest risks in this space Quality risk (variable purity, contamination, labeling issues) Physiology risk (more pathways affected, more unintended effects) 3) The GH/IGF-1 axis is where stacking gets most clinically delicate CJC-1295 has human data showing it raises GH/IGF-1
In fact, studies show that for those who are deficient in the nutrient, taking up to 2,000 micrograms per day is safe
It is manufactured to achieve a purity level exceeding 99%, verified through high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) testing methods to ensure quality and consistency